Literature DB >> 11711026

Inhibitory effect of bepridil on hKv1.5 channel current: comparison with amiodarone and E-4031.

S Kobayashi1, Y Reien, T Ogura, T Saito, Y Masuda, H Nakaya.   

Abstract

Effects of bepridil on the depolarization-activated outward K(+) currents (I(out)) in rat atrial myocytes and the human cardiac K(+) (hKv1.5) channel current stably expressed in human embryonic kidney (HEK) 293 cells were examined, and compared with those of amiodarone and N-[4-[[1-[2-(6-methyl-2-pyridinyl)ethyl]-4-piperidinyl]carbonyl]phenyl] methanesulphonamide dihydrochloride dihydrate (E-4031). Membrane currents were recorded using patch-clamp techniques in enzymatically isolated rat atrial myocytes and HEK 293 cells expressing hKv1.5 channels. Bepridil potently inhibited I(out) elicited by depolarization pulses and prolonged the action potential in rat atrial cells. Bepridil also inhibited the hKv1.5 channel current with the IC(50) value of 6.6 microM. The inhibitory effects of bepridil on the currents in HEK 293 cells were voltage-dependent. Amiodarone weakly inhibited rat atrial I(out) and hKv1.5 channel current. In contrast, E-4031 at a concentration of 10 microM had little influence on these currents. Thus, bepridil inhibits hKv1.5 channel current and the inhibitory effect may be useful for the treatment of atrial fibrillation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11711026     DOI: 10.1016/s0014-2999(01)01381-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

1.  Inhibitory effects of AMP 579, a novel cardioprotective adenosine A1/A2A receptor agonist, on native IKr and cloned HERG current.

Authors:  Noriko Saegusa; Toshiaki Sato; Takehiko Ogura; Issei Komuro; Haruaki Nakaya
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-11-19       Impact factor: 3.000

Review 2.  The contractile apparatus as a target for drugs against heart failure: interaction of levosimendan, a calcium sensitiser, with cardiac troponin c.

Authors:  Tia Sorsa; Piero Pollesello; R John Solaro
Journal:  Mol Cell Biochem       Date:  2004-11       Impact factor: 3.396

3.  Short- and long-term inhibition of cardiac inward-rectifier potassium channel current by an antiarrhythmic drug bepridil.

Authors:  Fangfang Ma; Hiroki Takanari; Kimiko Masuda; Masaki Morishima; Katsushige Ono
Journal:  Heart Vessels       Date:  2015-10-26       Impact factor: 2.037

4.  Bepridil up-regulates cardiac Na+ channels as a long-term effect by blunting proteasome signals through inhibition of calmodulin activity.

Authors:  L Kang; M Q Zheng; M Morishima; Y Wang; T Kaku; K Ono
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

5.  Targeted deletion of kcne2 impairs ventricular repolarization via disruption of I(K,slow1) and I(to,f).

Authors:  Torsten K Roepke; Andrianos Kontogeorgis; Christopher Ovanez; Xianghua Xu; Jeffrey B Young; Kerry Purtell; Peter A Goldstein; David J Christini; Nicholas S Peters; Fadi G Akar; David E Gutstein; Daniel J Lerner; Geoffrey W Abbott
Journal:  FASEB J       Date:  2008-07-04       Impact factor: 5.191

6.  The class III anti-arrhythmic agent, amiodarone, inhibits voltage-dependent K(+) channels in rabbit coronary arterial smooth muscle cells.

Authors:  Hongliang Li; Han Sol Kim; Hye Won Kim; Sung Eun Shin; Won-Kyo Jung; Kwon-Soo Ha; Eun-Taek Han; Seok-Ho Hong; Amy L Firth; Young Min Bae; Il-Whan Choi; Won Sun Park
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-03-31       Impact factor: 3.000

Review 7.  Endothelial and smooth muscle cell ion channels in pulmonary vasoconstriction and vascular remodeling.

Authors:  Ayako Makino; Amy L Firth; Jason X-J Yuan
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

8.  Comparison of the effects of bepridil and aprindine for the prevention of atrial fibrillation after cardiac and aortic surgery: A prospective randomized study.

Authors:  Mahito Ozawa; Takashi Komatsu; Yoshihiro Sato; Fusanori Kunugita; Hideaki Tachibana; Atsushi Tashiro; Hitoshi Okabayashi; Motoyuki Nakamura
Journal:  J Arrhythm       Date:  2015-05-16

Review 9.  Cardiac Potassium Channels: Physiological Insights for Targeted Therapy.

Authors:  Kamalan Jeevaratnam; Karan R Chadda; Christopher L-H Huang; A John Camm
Journal:  J Cardiovasc Pharmacol Ther       Date:  2017-09-25       Impact factor: 2.457

Review 10.  Challenges Faced with Small Molecular Modulators of Potassium Current Channel Isoform Kv1.5.

Authors:  Zefeng Zhao; Songsong Ruan; Xiaoming Ma; Qian Feng; Zhuosong Xie; Zhuang Nie; Peinan Fan; Mingcheng Qian; Xirui He; Shaoping Wu; Yongmin Zhang; Xiaohui Zheng
Journal:  Biomolecules       Date:  2019-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.